Wegovy, Zepbound, Saxenda, and other GLP-1 or GIP medications are needlessly out of reach for many Americans.

The health care industry is at a breaking point. Patients — health plan customers — feel unheard, undervalued, and exploited, ...

Clinical trials—and all the other studies that inform the health care each of us receives—have long had issues with most of ...

A caucus in the Pennsylvania House focused on maternal health has introduced bills that would protect the right to public ...

The measles outbreak in Texas has sparked debate over the use of vitamin A, with some health experts warning it may not be ...

Montgomery County, Pennsylvania, officials say a baby who has been diagnosed with measles visited two health care facilities ...

Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its stake in ...

Before ProPublica’s reporting on the deaths of Amber Thurman and Candi Miller, the names of committee members had been ...

The study ranked Minnesota as the best state for health care, while Mississippi ranked last. New York placed 38th in the ...

Adam Jentleson is a former chief of staff to Senator John Fetterman of Pennsylvania, a former deputy chief of staff to ...

Plaintiffs accused Sutter Health, a nonprofit, of illegally wielding its market power to drive up Californians' health care ...

Despite operating losses, Excellus Healthcare pointed to stronger-than-expected investment returns for helping the insurer ...